XBiotech Inc

Financials

Visão geral Relatórios Estatísticas Dividendos

Cash from operating activities -65.15 M69.44 M-14.82 M-18.73 M-30.96 M-39.92 M -39.92 M Cash from investing activities -3.73 M-3.52 M-63.89 M61.5 M-1.3 M-289 K -289 K Cash from financing activities -409.72 M-67.01 M0-9 00010.45 M-10.25 M -10.25 M Free cash flow -68.88 M65.92 M-15.41 M-19.09 M-32.27 M-40.21 M -40.21 M

XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.

XBIT

Financials

XBiotech Inc

Notícias

XBiotech shareholders approve board nominees and key proposals at annual meeting

XBiotech appoints Thomas Kündig and Craig Rademaker to board of directors